Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 4/20 | 0.52 |
| ▸ | CA1 | P00915 | 4/20 | 0.52 |
| ▸ | CA2 | P00918 | 4/20 | 0.52 |
| ▸ | CA9 | Q16790 | 4/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.47 |
| ▸ | ACHE | P22303 | 6/20 | 0.47 |
| ▸ | DGKA | P23743 | 1/20 | 0.47 |
| ▸ | EPHX2 | P34913 | 4/20 | 0.46 |
| ▸ | MAOA | P21397 | 1/20 | 0.43 |
| ▸ | MAOB | P27338 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31245821 | 0.98 | CA12 (0.49) | CA12CA1CA2CA9TDP1 | |
| SCHEMBL21842860 | 0.98 | CA12 (0.49) | CA12CA1CA2CA9TDP1 | |
| SCHEMBL31463303 | 0.94 | TDP1 (0.48) | CA12CA1CA2CA9TDP1 | |
| SCHEMBL31029307 | 0.93 | TDP1 (0.50) | CA12CA1CA2CA9TDP1 | |
| SCHEMBL25181487 | 0.93 | CA12 (0.59) | CA12CA1CA2CA9TDP1 | |
| SCHEMBL31284031 | 0.93 | CA12 (0.59) | CA12CA1CA2CA9TDP1 | |
| SCHEMBL25204665 | 0.91 | CA12 (0.44) | CA12CA1CA2CA9TDP1 | |
| SCHEMBL25201565 | 0.91 | CA12 (0.44) | CA12CA1CA2CA9TDP1 | |
| SCHEMBL25239638 | 0.91 | CA12 (0.44) | CA12CA1CA2CA9TDP1 | |
| SCHEMBL21842927 | 0.91 | DNM1 (0.43) | CA12CA1CA2CA9TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4687854-A2 | LIPIDS AND LIPID-LIKE COMPOUNDS FOR THERAPEUTIC LIPID NANOPARTICLE (LNP) DELIVERY | Flagship Labs 114, Inc. (US) | 2026-02-11 | — | — | EP | disclosed |
| WO-2024211865-A2 | LIPIDS AND LIPID-LIKE COMPOUNDS FOR THERAPEUTIC LIPID NANOPARTICLE (LNP) DELIVERY | OMEGA THERAPEUTICS, INC. (US) | 2024-10-10 | — | — | WO | disclosed |